Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$187,046,929
+$47,737,200 QoQ
Shares Held
516,533
+30.5% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#93
of 3,158 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $2,708,459,664 across 8 Drug Manufacturers - General names. AMGN ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,210,321 | $1,451,695,438 | |
| 2 | ABBV |
AbbVie Inc.
|
1,613,385 | $405,992,201 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,259,422 | $290,335,727 | |
| 4 | AMGN |
Amgen Inc
This page
|
516,533 | $187,046,929 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,197,619 | $151,307,184 | |
| 6 | PFE |
Pfizer Inc
|
4,179,623 | $100,645,321 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,691,386 | $97,457,661 | |
| 8 | BIIB |
Biogen Inc.
|
110,984 | $23,979,203 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,046,929 | 516,533 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $139,309,729 | 395,935 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $135,227,144 | 413,147 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $124,191,140 | 440,082 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $123,171,816 | 441,144 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $135,148,209 | 433,793 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $171,630,658 | 658,497 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $65,080,942 | 201,983 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $196,760,075 | 629,733 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $160,162,289 | 563,317 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $170,013,021 | 590,282 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $167,132,974 | 621,867 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $156,538,531 | 705,065 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $161,152,725 | 666,609 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $204,738,385 | 779,540 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $62,878,260 | 278,963 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $78,079,592 | 320,919 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $54,785,530 | 226,555 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $67,690,773 | 300,888 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $53,551,649 | 251,830 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,304,187 | 292,530 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $88,226,781 | 354,595 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $132,438,978 | 576,022 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $184,301,074 | 725,138 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $198,624,310 | 842,128 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $148,460,192 | 732,305 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||